Asciminib: A New Treatment Option in Patients With P-Loop Mutations: Case Report

被引：0
|
作者：
Pirciulescu, Nicoleta [1 ]
Dragomir, Mihaela [2 ]
Dobrea, Camelia [1 ,2 ]
Costache, Simona [1 ]
Crisan, Ana Manuela [1 ,2 ]
机构：
[1] Fundeni Clin Inst, Hematol & Bone Marrow Transplantat Dept, Bucharest, Romania
[2] Carol Davila Univ Med & Pharm, Bucharest, Romania
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
CML; asciminib; P-loop mutation; prognosis; case;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CML-602
引用
收藏
页码：S376 / S376
页数：1
相关论文
共 50 条
  • [21] Impacts of Mutations in the P-Loop on Conformational Alterations of KRAS Investigated with Gaussian Accelerated Molecular Dynamics Simulations
    Shi, Shuhua
    Zheng, Linqi
    Ren, Yonglian
    Wang, Ziyu
    MOLECULES, 2023, 28 (07):
  • [22] Altered ionic selectivity of the Na+ channel revealed by cysteine mutations in the P-loop of domain IV
    Tsushima, R
    Li, R
    Backx, P
    BIOPHYSICAL JOURNAL, 1996, 70 (02) : SUPM6 - SUPM6
  • [23] Report on a case of fibrogenesis imperfecta ossium and a possible new treatment option
    Bakos, B.
    Lukats, A.
    Lakatos, P.
    Gyori, G.
    Tremmel, A.
    Takacs, I.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (05) : 1643 - 1646
  • [24] Oral melanoacanthoma: A case report, a review of the literature and a new treatment option
    Andrews, BT
    Trask, DK
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2005, 114 (09): : 677 - 680
  • [25] Report on a case of fibrogenesis imperfecta ossium and a possible new treatment option
    B. Bakos
    Á. Lukáts
    P. Lakatos
    G. Győri
    A. Tremmel
    I. Takács
    Osteoporosis International, 2014, 25 : 1643 - 1646
  • [26] Intragenic suppressors of P-loop mutations in the beta-subunit of the mitochondrial ATPase in the yeast Saccharomyces cerevisiae
    Shen, HG
    SosaPeinado, A
    Mueller, DM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (20) : 11844 - 11851
  • [27] Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis
    Branford, S
    Rudzki, Z
    Walsh, S
    Parkinson, I
    Grigg, A
    Szer, J
    Taylor, K
    Herrmann, R
    Seymour, JF
    Arthur, C
    Joske, D
    Lynch, K
    Hughes, T
    BLOOD, 2003, 102 (01) : 276 - 283
  • [28] BCR-ABL kinase domain mutations in CML patients on imatinib: Incidence is correlated with duration of CML and mutations in the P-loop may be indicative of a poor outcome.
    Branford, S
    Walsh, S
    Rudzki, Z
    Grigg, A
    Taylor, K
    Herrmann, R
    Szer, J
    Seymour, J
    Arthur, C
    Lynch, K
    Hughes, T
    BLOOD, 2002, 100 (11) : 367A - 367A
  • [29] Twin pregnancy during treatment with asciminib for chronic myeloid leukemia - a case report
    Pereira, Gessika B. G. M. Gutierrez de Moraes
    Rocha, Victor A.
    Barbosa, Paulo Victor R.
    Cralcev, Christopher
    de Jesus, Alice V.
    Spadoni, Mariana B.
    Pereira, Teresa Vilela V.
    Magalhaes, Joao Paulo C.
    Duarte, Gislaine O.
    Duffles, Guilherme
    Maia, Felipe S.
    Surita, Fernanda
    Guida, Jose Paulo S.
    de Souza, Carmino Antonio
    Costa, Maria Laura
    Pagnano, Katia B. B.
    ANNALS OF HEMATOLOGY, 2025, : 2051 - 2054
  • [30] New treatment option for an incomplete vertical root fracture–a preliminary case report
    Paul Henryk Hadrossek
    Till Dammaschke
    Head & Face Medicine, 10
12345